Analysis | Metabolite Name | Measured Value | Units | CASE_CONTROL | Chemotherapy | Drug | Race | TIMEPOINT | Tamoxyfen | Taxane |
---|---|---|---|---|---|---|---|---|---|---|
Reversed phase NEGATIVE ION MODE | PINITOL (CAS# 10284-63-6); (M+CL)- | 1829 | Peak area | Case | N | Letrozole | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | PINITOL (CAS# 10284-63-6); (M+CL)- | 4158 | Peak area | Control | Y | Exemestane | White | 3 Month | Y | Y |
Reversed phase NEGATIVE ION MODE | PINITOL (CAS# 10284-63-6); (M+CL)- | Peak area | Case | N | Exemestane | Black | 3 Month | N | N | |
Reversed phase NEGATIVE ION MODE | PINITOL (CAS# 10284-63-6); (M+CL)- | Peak area | Case | N | Exemestane | Black | Baseline | N | N | |
Reversed phase NEGATIVE ION MODE | PINITOL (CAS# 10284-63-6); (M+CL)- | Peak area | Case | N | Exemestane | White | 3 Month | N | N | |
Reversed phase NEGATIVE ION MODE | PINITOL (CAS# 10284-63-6); (M+CL)- | Peak area | Case | N | Exemestane | White | 3 Month | Y | N | |
Reversed phase NEGATIVE ION MODE | PINITOL (CAS# 10284-63-6); (M+CL)- | Peak area | Case | N | Exemestane | White | Baseline | N | N | |
Reversed phase NEGATIVE ION MODE | PINITOL (CAS# 10284-63-6); (M+CL)- | Peak area | Case | N | Exemestane | White | Baseline | Y | N | |
Reversed phase NEGATIVE ION MODE | PINITOL (CAS# 10284-63-6); (M+CL)- | Peak area | Case | N | Letrozole | Black | 3 Month | N | N | |
Reversed phase NEGATIVE ION MODE | PINITOL (CAS# 10284-63-6); (M+CL)- | Peak area | Case | N | Letrozole | Black | Baseline | N | N | |
Reversed phase NEGATIVE ION MODE | PINITOL (CAS# 10284-63-6); (M+CL)- | Peak area | Case | N | Letrozole | White | 3 Month | N | N | |
Reversed phase NEGATIVE ION MODE | PINITOL (CAS# 10284-63-6); (M+CL)- | Peak area | Case | N | Letrozole | White | 3 Month | Y | N | |
Reversed phase NEGATIVE ION MODE | PINITOL (CAS# 10284-63-6); (M+CL)- | Peak area | Case | N | Letrozole | White | Baseline | N | N | |
Reversed phase NEGATIVE ION MODE | PINITOL (CAS# 10284-63-6); (M+CL)- | Peak area | Case | N | Letrozole | White | Baseline | Y | N | |
Reversed phase NEGATIVE ION MODE | PINITOL (CAS# 10284-63-6); (M+CL)- | Peak area | Case | Y | Exemestane | Black | 3 Month | N | Y | |
Reversed phase NEGATIVE ION MODE | PINITOL (CAS# 10284-63-6); (M+CL)- | Peak area | Case | Y | Exemestane | Black | Baseline | N | Y | |
Reversed phase NEGATIVE ION MODE | PINITOL (CAS# 10284-63-6); (M+CL)- | Peak area | Case | Y | Exemestane | White | 3 Month | N | Y | |
Reversed phase NEGATIVE ION MODE | PINITOL (CAS# 10284-63-6); (M+CL)- | Peak area | Case | Y | Exemestane | White | 3 Month | Y | N | |
Reversed phase NEGATIVE ION MODE | PINITOL (CAS# 10284-63-6); (M+CL)- | Peak area | Case | Y | Exemestane | White | 3 Month | Y | Y | |
Reversed phase NEGATIVE ION MODE | PINITOL (CAS# 10284-63-6); (M+CL)- | Peak area | Case | Y | Exemestane | White | Baseline | N | Y | |
Reversed phase NEGATIVE ION MODE | PINITOL (CAS# 10284-63-6); (M+CL)- | Peak area | Case | Y | Exemestane | White | Baseline | Y | N | |
Reversed phase NEGATIVE ION MODE | PINITOL (CAS# 10284-63-6); (M+CL)- | Peak area | Case | Y | Exemestane | White | Baseline | Y | Y | |
Reversed phase NEGATIVE ION MODE | PINITOL (CAS# 10284-63-6); (M+CL)- | Peak area | Case | Y | Letrozole | White | 3 Month | Y | Y | |
Reversed phase NEGATIVE ION MODE | PINITOL (CAS# 10284-63-6); (M+CL)- | Peak area | Case | Y | Letrozole | White | Baseline | Y | Y | |
Reversed phase NEGATIVE ION MODE | PINITOL (CAS# 10284-63-6); (M+CL)- | Peak area | Control | N | Exemestane | Black | 3 Month | Y | N | |
Reversed phase NEGATIVE ION MODE | PINITOL (CAS# 10284-63-6); (M+CL)- | Peak area | Control | N | Exemestane | Black | Baseline | Y | N | |
Reversed phase NEGATIVE ION MODE | PINITOL (CAS# 10284-63-6); (M+CL)- | Peak area | Control | N | Exemestane | White | 3 Month | N | N | |
Reversed phase NEGATIVE ION MODE | PINITOL (CAS# 10284-63-6); (M+CL)- | Peak area | Control | N | Exemestane | White | 3 Month | Y | N | |
Reversed phase NEGATIVE ION MODE | PINITOL (CAS# 10284-63-6); (M+CL)- | Peak area | Control | N | Exemestane | White | Baseline | N | N | |
Reversed phase NEGATIVE ION MODE | PINITOL (CAS# 10284-63-6); (M+CL)- | Peak area | Control | N | Exemestane | White | Baseline | Y | N | |
Reversed phase NEGATIVE ION MODE | PINITOL (CAS# 10284-63-6); (M+CL)- | Peak area | Control | N | Letrozole | Black | 3 Month | N | N | |
Reversed phase NEGATIVE ION MODE | PINITOL (CAS# 10284-63-6); (M+CL)- | Peak area | Control | N | Letrozole | Black | Baseline | N | N | |
Reversed phase NEGATIVE ION MODE | PINITOL (CAS# 10284-63-6); (M+CL)- | Peak area | Control | N | Letrozole | White | 3 Month | N | N | |
Reversed phase NEGATIVE ION MODE | PINITOL (CAS# 10284-63-6); (M+CL)- | Peak area | Control | N | Letrozole | White | 3 Month | Y | N | |
Reversed phase NEGATIVE ION MODE | PINITOL (CAS# 10284-63-6); (M+CL)- | Peak area | Control | N | Letrozole | White | Baseline | N | N | |
Reversed phase NEGATIVE ION MODE | PINITOL (CAS# 10284-63-6); (M+CL)- | Peak area | Control | N | Letrozole | White | Baseline | Y | N | |
Reversed phase NEGATIVE ION MODE | PINITOL (CAS# 10284-63-6); (M+CL)- | Peak area | Control | Y | Exemestane | White | 3 Month | N | N | |
Reversed phase NEGATIVE ION MODE | PINITOL (CAS# 10284-63-6); (M+CL)- | Peak area | Control | Y | Exemestane | White | 3 Month | N | Y | |
Reversed phase NEGATIVE ION MODE | PINITOL (CAS# 10284-63-6); (M+CL)- | Peak area | Control | Y | Exemestane | White | 3 Month | Y | N | |
Reversed phase NEGATIVE ION MODE | PINITOL (CAS# 10284-63-6); (M+CL)- | Peak area | Control | Y | Exemestane | White | Baseline | N | N | |
Reversed phase NEGATIVE ION MODE | PINITOL (CAS# 10284-63-6); (M+CL)- | Peak area | Control | Y | Exemestane | White | Baseline | N | Y | |
Reversed phase NEGATIVE ION MODE | PINITOL (CAS# 10284-63-6); (M+CL)- | Peak area | Control | Y | Exemestane | White | Baseline | Y | N | |
Reversed phase NEGATIVE ION MODE | PINITOL (CAS# 10284-63-6); (M+CL)- | Peak area | Control | Y | Exemestane | White | Baseline | Y | Y | |
Reversed phase NEGATIVE ION MODE | PINITOL (CAS# 10284-63-6); (M+CL)- | Peak area | Control | Y | Letrozole | White | 3 Month | Y | N | |
Reversed phase NEGATIVE ION MODE | PINITOL (CAS# 10284-63-6); (M+CL)- | Peak area | Control | Y | Letrozole | White | 3 Month | Y | Y | |
Reversed phase NEGATIVE ION MODE | PINITOL (CAS# 10284-63-6); (M+CL)- | Peak area | Control | Y | Letrozole | White | Baseline | Y | N | |
Reversed phase NEGATIVE ION MODE | PINITOL (CAS# 10284-63-6); (M+CL)- | Peak area | Control | Y | Letrozole | White | Baseline | Y | Y | |
Reversed phase POSITIVE ION MODE | PINITOL (CAS# 10284-63-6); (M+NA)+ | 1223 | Peak area | Control | N | Letrozole | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | PINITOL (CAS# 10284-63-6); (M+NA)+ | 1249 | Peak area | Control | Y | Exemestane | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | PINITOL (CAS# 10284-63-6); (M+NA)+ | 1590 | Peak area | Case | N | Letrozole | Black | Baseline | N | N |
Reversed phase POSITIVE ION MODE | PINITOL (CAS# 10284-63-6); (M+NA)+ | 1733 | Peak area | Case | Y | Exemestane | White | Baseline | N | Y |
Reversed phase POSITIVE ION MODE | PINITOL (CAS# 10284-63-6); (M+NA)+ | 1888 | Peak area | Control | Y | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | PINITOL (CAS# 10284-63-6); (M+NA)+ | 1920 | Peak area | Case | N | Letrozole | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | PINITOL (CAS# 10284-63-6); (M+NA)+ | 1922 | Peak area | Control | N | Letrozole | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | PINITOL (CAS# 10284-63-6); (M+NA)+ | 2010 | Peak area | Control | N | Letrozole | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | PINITOL (CAS# 10284-63-6); (M+NA)+ | 2077 | Peak area | Control | Y | Exemestane | White | Baseline | N | Y |
Reversed phase POSITIVE ION MODE | PINITOL (CAS# 10284-63-6); (M+NA)+ | 2551 | Peak area | Control | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase POSITIVE ION MODE | PINITOL (CAS# 10284-63-6); (M+NA)+ | 2832 | Peak area | Case | N | Exemestane | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | PINITOL (CAS# 10284-63-6); (M+NA)+ | 2955 | Peak area | Control | Y | Exemestane | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | PINITOL (CAS# 10284-63-6); (M+NA)+ | 2994 | Peak area | Case | N | Exemestane | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | PINITOL (CAS# 10284-63-6); (M+NA)+ | 3065 | Peak area | Case | Y | Exemestane | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | PINITOL (CAS# 10284-63-6); (M+NA)+ | 3215 | Peak area | Control | N | Letrozole | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | PINITOL (CAS# 10284-63-6); (M+NA)+ | 3230 | Peak area | Control | N | Exemestane | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | PINITOL (CAS# 10284-63-6); (M+NA)+ | 3341 | Peak area | Control | N | Exemestane | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | PINITOL (CAS# 10284-63-6); (M+NA)+ | 3555 | Peak area | Case | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase POSITIVE ION MODE | PINITOL (CAS# 10284-63-6); (M+NA)+ | 4188 | Peak area | Control | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase POSITIVE ION MODE | PINITOL (CAS# 10284-63-6); (M+NA)+ | 4430 | Peak area | Control | N | Letrozole | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | PINITOL (CAS# 10284-63-6); (M+NA)+ | 5065 | Peak area | Case | Y | Exemestane | White | Baseline | N | Y |
Reversed phase POSITIVE ION MODE | PINITOL (CAS# 10284-63-6); (M+NA)+ | 5258 | Peak area | Case | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase POSITIVE ION MODE | PINITOL (CAS# 10284-63-6); (M+NA)+ | 5291 | Peak area | Control | N | Letrozole | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | PINITOL (CAS# 10284-63-6); (M+NA)+ | 5516 | Peak area | Case | N | Exemestane | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | PINITOL (CAS# 10284-63-6); (M+NA)+ | 5519 | Peak area | Case | Y | Exemestane | White | Baseline | N | Y |
Reversed phase POSITIVE ION MODE | PINITOL (CAS# 10284-63-6); (M+NA)+ | 5519 | Peak area | Case | Y | Exemestane | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | PINITOL (CAS# 10284-63-6); (M+NA)+ | 5521 | Peak area | Control | N | Exemestane | Black | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | PINITOL (CAS# 10284-63-6); (M+NA)+ | 5675 | Peak area | Case | N | Letrozole | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | PINITOL (CAS# 10284-63-6); (M+NA)+ | 5863 | Peak area | Control | N | Letrozole | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | PINITOL (CAS# 10284-63-6); (M+NA)+ | 5989 | Peak area | Control | N | Letrozole | Black | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | PINITOL (CAS# 10284-63-6); (M+NA)+ | 6127 | Peak area | Case | Y | Exemestane | White | Baseline | N | Y |
Reversed phase POSITIVE ION MODE | PINITOL (CAS# 10284-63-6); (M+NA)+ | 6736 | Peak area | Case | N | Letrozole | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | PINITOL (CAS# 10284-63-6); (M+NA)+ | 6844 | Peak area | Case | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase POSITIVE ION MODE | PINITOL (CAS# 10284-63-6); (M+NA)+ | 7125 | Peak area | Case | Y | Letrozole | White | Baseline | Y | Y |
Reversed phase POSITIVE ION MODE | PINITOL (CAS# 10284-63-6); (M+NA)+ | 7892 | Peak area | Case | N | Exemestane | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | PINITOL (CAS# 10284-63-6); (M+NA)+ | 8779 | Peak area | Case | N | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | PINITOL (CAS# 10284-63-6); (M+NA)+ | 8840 | Peak area | Case | N | Exemestane | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | PINITOL (CAS# 10284-63-6); (M+NA)+ | 8860 | Peak area | Control | N | Letrozole | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | PINITOL (CAS# 10284-63-6); (M+NA)+ | 9714 | Peak area | Case | N | Letrozole | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | PINITOL (CAS# 10284-63-6); (M+NA)+ | 9954 | Peak area | Case | N | Letrozole | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | PINITOL (CAS# 10284-63-6); (M+NA)+ | 10424 | Peak area | Case | N | Exemestane | Black | Baseline | N | N |
Reversed phase POSITIVE ION MODE | PINITOL (CAS# 10284-63-6); (M+NA)+ | 11085 | Peak area | Control | N | Letrozole | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | PINITOL (CAS# 10284-63-6); (M+NA)+ | 11955 | Peak area | Control | Y | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | PINITOL (CAS# 10284-63-6); (M+NA)+ | 11975 | Peak area | Case | N | Letrozole | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | PINITOL (CAS# 10284-63-6); (M+NA)+ | 12757 | Peak area | Control | Y | Exemestane | White | Baseline | Y | Y |
Reversed phase POSITIVE ION MODE | PINITOL (CAS# 10284-63-6); (M+NA)+ | 14075 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | PINITOL (CAS# 10284-63-6); (M+NA)+ | 14297 | Peak area | Case | N | Letrozole | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | PINITOL (CAS# 10284-63-6); (M+NA)+ | 14886 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | PINITOL (CAS# 10284-63-6); (M+NA)+ | 15055 | Peak area | Case | N | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | PINITOL (CAS# 10284-63-6); (M+NA)+ | 19423 | Peak area | Control | N | Exemestane | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | PINITOL (CAS# 10284-63-6); (M+NA)+ | 20912 | Peak area | Case | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase POSITIVE ION MODE | PINITOL (CAS# 10284-63-6); (M+NA)+ | 23188 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | PINITOL (CAS# 10284-63-6); (M+NA)+ | 33748 | Peak area | Control | N | Exemestane | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | PINITOL (CAS# 10284-63-6); (M+NA)+ | 42424 | Peak area | Control | Y | Exemestane | White | 3 Month | Y | Y |
Reversed phase POSITIVE ION MODE | PINITOL (CAS# 10284-63-6); (M+NA)+ | 43178 | Peak area | Case | Y | Letrozole | White | 3 Month | Y | Y |
Reversed phase POSITIVE ION MODE | PINITOL (CAS# 10284-63-6); (M+NA)+ | Peak area | Case | N | Exemestane | Black | 3 Month | N | N | |
Reversed phase POSITIVE ION MODE | PINITOL (CAS# 10284-63-6); (M+NA)+ | Peak area | Case | N | Exemestane | White | 3 Month | N | N | |
Reversed phase POSITIVE ION MODE | PINITOL (CAS# 10284-63-6); (M+NA)+ | Peak area | Case | N | Exemestane | White | 3 Month | Y | N | |
Reversed phase POSITIVE ION MODE | PINITOL (CAS# 10284-63-6); (M+NA)+ | Peak area | Case | N | Exemestane | White | Baseline | N | N | |
Reversed phase POSITIVE ION MODE | PINITOL (CAS# 10284-63-6); (M+NA)+ | Peak area | Case | N | Exemestane | White | Baseline | Y | N | |
Reversed phase POSITIVE ION MODE | PINITOL (CAS# 10284-63-6); (M+NA)+ | Peak area | Case | N | Letrozole | Black | 3 Month | N | N | |
Reversed phase POSITIVE ION MODE | PINITOL (CAS# 10284-63-6); (M+NA)+ | Peak area | Case | N | Letrozole | White | 3 Month | N | N | |
Reversed phase POSITIVE ION MODE | PINITOL (CAS# 10284-63-6); (M+NA)+ | Peak area | Case | N | Letrozole | White | Baseline | N | N | |
Reversed phase POSITIVE ION MODE | PINITOL (CAS# 10284-63-6); (M+NA)+ | Peak area | Case | Y | Exemestane | Black | 3 Month | N | Y | |
Reversed phase POSITIVE ION MODE | PINITOL (CAS# 10284-63-6); (M+NA)+ | Peak area | Case | Y | Exemestane | Black | Baseline | N | Y | |
Reversed phase POSITIVE ION MODE | PINITOL (CAS# 10284-63-6); (M+NA)+ | Peak area | Case | Y | Exemestane | White | 3 Month | Y | N | |
Reversed phase POSITIVE ION MODE | PINITOL (CAS# 10284-63-6); (M+NA)+ | Peak area | Case | Y | Exemestane | White | 3 Month | Y | Y | |
Reversed phase POSITIVE ION MODE | PINITOL (CAS# 10284-63-6); (M+NA)+ | Peak area | Case | Y | Exemestane | White | Baseline | Y | N | |
Reversed phase POSITIVE ION MODE | PINITOL (CAS# 10284-63-6); (M+NA)+ | Peak area | Case | Y | Exemestane | White | Baseline | Y | Y | |
Reversed phase POSITIVE ION MODE | PINITOL (CAS# 10284-63-6); (M+NA)+ | Peak area | Case | Y | Letrozole | White | 3 Month | Y | Y | |
Reversed phase POSITIVE ION MODE | PINITOL (CAS# 10284-63-6); (M+NA)+ | Peak area | Case | Y | Letrozole | White | Baseline | Y | Y | |
Reversed phase POSITIVE ION MODE | PINITOL (CAS# 10284-63-6); (M+NA)+ | Peak area | Control | N | Exemestane | Black | Baseline | Y | N | |
Reversed phase POSITIVE ION MODE | PINITOL (CAS# 10284-63-6); (M+NA)+ | Peak area | Control | N | Exemestane | White | 3 Month | N | N | |
Reversed phase POSITIVE ION MODE | PINITOL (CAS# 10284-63-6); (M+NA)+ | Peak area | Control | N | Exemestane | White | 3 Month | Y | N | |
Reversed phase POSITIVE ION MODE | PINITOL (CAS# 10284-63-6); (M+NA)+ | Peak area | Control | N | Exemestane | White | Baseline | N | N | |
Reversed phase POSITIVE ION MODE | PINITOL (CAS# 10284-63-6); (M+NA)+ | Peak area | Control | N | Letrozole | Black | Baseline | N | N | |
Reversed phase POSITIVE ION MODE | PINITOL (CAS# 10284-63-6); (M+NA)+ | Peak area | Control | N | Letrozole | White | 3 Month | Y | N | |
Reversed phase POSITIVE ION MODE | PINITOL (CAS# 10284-63-6); (M+NA)+ | Peak area | Control | N | Letrozole | White | Baseline | N | N | |
Reversed phase POSITIVE ION MODE | PINITOL (CAS# 10284-63-6); (M+NA)+ | Peak area | Control | N | Letrozole | White | Baseline | Y | N | |
Reversed phase POSITIVE ION MODE | PINITOL (CAS# 10284-63-6); (M+NA)+ | Peak area | Control | Y | Exemestane | White | 3 Month | Y | N | |
Reversed phase POSITIVE ION MODE | PINITOL (CAS# 10284-63-6); (M+NA)+ | Peak area | Control | Y | Exemestane | White | Baseline | N | N | |
Reversed phase POSITIVE ION MODE | PINITOL (CAS# 10284-63-6); (M+NA)+ | Peak area | Control | Y | Exemestane | White | Baseline | N | Y | |
Reversed phase POSITIVE ION MODE | PINITOL (CAS# 10284-63-6); (M+NA)+ | Peak area | Control | Y | Exemestane | White | Baseline | Y | N | |
Reversed phase POSITIVE ION MODE | PINITOL (CAS# 10284-63-6); (M+NA)+ | Peak area | Control | Y | Letrozole | White | 3 Month | Y | N | |
Reversed phase POSITIVE ION MODE | PINITOL (CAS# 10284-63-6); (M+NA)+ | Peak area | Control | Y | Letrozole | White | 3 Month | Y | Y | |
Reversed phase POSITIVE ION MODE | PINITOL (CAS# 10284-63-6); (M+NA)+ | Peak area | Control | Y | Letrozole | White | Baseline | Y | N | |
Reversed phase POSITIVE ION MODE | PINITOL (CAS# 10284-63-6); (M+NA)+ | Peak area | Control | Y | Letrozole | White | Baseline | Y | Y |